As per the latest report by IMARC Group, the global heparin market size reached reached a value of US$ 6.7 Billion in 2020.  Heparin (C12H19NO20S3) is an anticoagulant (blood thinner) that assists in preventing thromboembolic complications.

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Heparin Market
Research Report and
Forecast 2021-2026
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Heparin Market Outlook 2026:
As per the latest report by IMARC Group, titled “Heparin Market: Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2021-2026,” the global heparin market size reached reached a value
of US$ 6.7 Billion in 2020.
Heparin (C12H19NO20S3) is an anticoagulant (blood thinner) that assists in preventing
thromboembolic complications. In this complication, clots travel from their site of origin to clog up
another vessel through the bloodstream.
Heparin is generally injected into the muscle or the veins to break up clots and maintain the smooth
fluidity of the blood.
Therefore, it is utilized in the treatment of heart conditions and unstable angina. Besides this, it is also
used in post-surgeries, and during dialysis and blood transfusion.
Request for a free sample report: https://www.imarcgroup.com/heparin-market/requestsample

4. Report Description
Report Description and Highlights
Global Heparin Market Trends:
The growing cases of vascular diseases, such as deep vein thrombosis (DVT) and pulmonary embolism
(PE), represent one of the significant factors that are positively influencing the demand for heparin
across the globe.
Heparin has been proven to be an effective drug for venous thromboembolism and cardiovascular
disorders (CVDs), which is also fueling the market growth.
The market is also driven by numerous advancements in the field of carbohydrate synthesis, which
include building block preparation, coupling reactions and the development of convergent strategies.
Apart from this, the availability of synthetic and semi-synthetic heparin mimetics, which assist in
treating various types of cancer, coagulation and inflammatory diseases, is anticipated to bolster the
market growth in the upcoming years.

5. Market Summary:
Breakup by product Type:
• Unfractionated
• Low molecular weight heparin
• Ultra-low molecular weight heparin
Breakup by Source:
• Bovine
• Porcine
Breakup by Distribution Channel:
• Hospital pharmacies
• Retail pharmacies
• Drug stores
• Online stores
Report Description
Report Description and Highlights

6. Breakup by Mode:
• Oral
• Parenteral
Breakup by Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Furthermore, some of the leading biopharmaceutical companies are increasing their budget for
research and development (R&D) to improve the therapeutic potential of heparin and reduce its side-
effects.
Report Description
Report Description and Highlights

7. Breakup by Application:
• Atrial fibrillation and heart attack
• Stroke
• Deep vein thrombosis
• Pulmonary embolism
Breakup by End-Use:
• Hospitals
• Clinics
• Homecare settings
• Ambulatory surgical centers
On account of the aforementioned factors, the market is expected to witness moderate growth during
2021-2026.
Report Description
Report Description and Highlights

8. Competitive Landscape With Keyplayer:
• GlaxoSmithKline Plc
• Shenzhen Hepalink Pharmaceutical Co. Ltd
• Pfizer Inc.
• LEO Pharma A/S
• Sanofi S.A.
• Dr. Reddy’s Laboratories Ltd.
• Teva Pharmaceutical Industries Ltd.
• Aspen Holdings
• LEO Pharma A/S
• Baxter International Inc.
• Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
• Sandoz International GmbH
• Opocrin S.p.A.
• Sichuan Deebio Pharmaceutical Co. Ltd.
• Dongying Tiandong Pharmaceutical Co. Ltd.
View Report TOC, Figures and Tables : https://www.imarcgroup.com/heparin-market
Report Description
Report Description and Highlights

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

11. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

12. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us